Attempts to positively influence the practices, attitudes and health behaviors of people thrive on principles and methods used and adapted notions of social communication, health education, social marketing, behavior analysis, anthropology and other social sciences and related health. In the field of HIV / AIDS and other STIs, these initiatives seek to inform and educate the public, raising awareness and promoting preventive attitudes, promote change risky behaviors, promoting attitudes of respect, tolerance, solidarity and non-discrimination against people affected by HIV / AIDS and their environment and engage community participation and media in prevention efforts.
The component development and community education Impacts performs in the field of education interventions, communication and education. Maintains close contact with the community through the implementation of community development activities, developing educational lectures, participation in campaigns and health fairs, production and distribution of informational and educational materials, information services, and implementation of mass media campaigns.
IMPACTA aims to train researchers in quality, for this purpose has agreements with universities dedicated to biomedical research. IMPACTA members are professors from universities of national and international reputation in the clinical invesigación. The training programs are aimed IMPACTA this select staff coordinators in coordination with universities who have IMPACTA agreement.
IMPACTA has participated in the formation of a curriculum within the training program called INCAS (Latin America's Program for Research and Training in AIDS) which has been completed and is currently working IMPACTA in search of developing a Training Program Research Internacionsal based AIDS in Peru.
UNIVERSITY OF KENTUCKY
I recently graduated from the School of Medicine of the University of Kentucky and participated in a mentoring program and research (RAMP for its acronym in English) Vaccine Network. I decided to conduct my research in HIV prevention Impact team because I was so impressed by the work that researchers have been publishing this venue. My research was about prevention of HIV, and this women focused on transgender, understudied population, and sometimes misunderstood in Peru.
Epidemiological studies of transgender women in Peru underscore the need to identify effective methods to prevent HIV infection in this community. To develop an effective vaccine against HIV, which is acceptable to transgender women, requires researchers to understand the personal and social barriers exist to participation in clinical trials. The study aims to examine the barriers and facilitators to participation of transgender women in trials of vaccines and other HIV prevention trials. The study was conducted in Lima and Callao. The information collected in this study will develop recommendations for improving the participation of transgender women in HIV prevention studies.
UNIVERSITY OF COLUMBIA
I'm a medical student at Columbia University in New York. A few months ago I was given the International Fellowship to conduct a Doris Duke Clinical Research for 6 months in Peru. I was fortunate to work my IMPACTA project.
IMPACTA chose to be a research center with incredible resources and have a very nice team to a young researcher like me. Internationally, Impact is recognized as the leading HIV research in Latin America. Impacts During my work I investigated the "Knowledge of HIV prevention methods among men who have sex with men", which included the attitudes and willingness of health care providers to use Pre-exposure prophylaxis as a prevention method HIV in Lima, Peru.
UNIVERSITY OF ALABAMA
As a medical student at the University of Alabama, received a grant from the "Research and Mentoring Program" (RAMP for its acronym in English) of the Network Study HIV Vaccine, with which I could work my research project Alabama one year and one month in Impact. My project compared the opinions of Americans and Peruvians about the different HIV prevention strategies. Of these two groups watched their perceptions about condoms, circumcision, pre-exposure prophylaxis, HIV vaccine and microbicides.
Thanks to the support and guidance of the Impact team, I managed to reach my goals on schedule. That's why I chose to do my project here, its infrastructure and team leaders make HIV research in South America.
ENRICO FERRO & DAMIAN WEIKUM
UNIVERSITY OF YALE
As students of the School of Medicine, Yale University, were able to access a grant from our university, which had the opportunity to work on Impacts for 3 months. Our project was to investigate whether there is a correlation between the use of alcohol, mental impairment and antiretroviral treatment outcomes of 300 men who have sex with men (MSM) living with HIV. In parallel, we observe whether this effect would have some implications for future prevention and treatment methodologies AIDS.
We achieved all our goals set by the support of Dr. Jesús Peinado and Dr. Pedro Gonzales, our mentor Dr. Frederick Altice, and the entire team clinics Barranco and San Miguel. We are confident that the data collected from this research will help to provide more information to create better strategies to prevent alcohol abuse in the MSM population.
ESTUDIANTE DE MEDICINA
UNIVERSITY OF COLUMBIA
I came to Peru thanks to a grant from the Doris Duke Foundation, which allows me to do my research study on Impacts for 8 months.
My study is to know what they know relatives who are contacts of a TB patient, about tuberculosis diagnosis, treatment, prevention and the use of vaccines to prevent infection. Although there is no vaccine against TB, part of the study is to know how willing would the contacts, to participate in a study of vaccines against TB. We enroll approximately 200 participants in Lima.
This study was carried out with the help of Dr. Javier Lama and Ms. Patricia Segura of Impacts and collaboration of Dr. Leonid Lecca and Ms. Carmen Contreras of the NGO Partners in Health.
Latin American Program on AIDS Research and Training
INCAS aims to implement training activities aimed at increasing the capacity of Latin American researchers and AIDS, helping to sustain the continuity in efforts to prevent HIV acquisition and provision of quality health care to people who living with HIV in Latin America.
INCAS is promoting this task with the support of an initial two-year grant provided by the National Institutes of Health in the United States (U.S. NIH). In this first phase, INCA is presented as specific goals:
1. Assess training needs in research in HIV / AIDS research sites sponsored by the National Institutes of Health in the United States (U.S. NIH) in Latin America. This task involves identifying areas of study in which there is no training or required, the establishment of priorities and the design of courses and programs based on identified needs, and the definition of the best methods to provide the training required (or distance courses, mentor duets-trained, certified courses and, ideally, a master's program in clinical research).
2. Strengthen and expand partnerships between academic and research institutions working on AIDS in Latin America. For this work provides for the formalization of institutional arrangements that facilitate the development of certification and master's programs (including evaluation systems capacity to implement web-based education).
3. Develop a complete application for international funds to establish the Research and Training Programme on AIDS in the Second Year.
Institutions based in Peru:
Civil Partnership Impacts Health and Education / Health Medical Research (Dr. Jorge Sanchez)
Universidad Nacional Mayor de San Marcos (Dr. Jorge Alarcon)
University of San Martin de Porres (Dr. Sixto Sanchez)
Research Center for Tropical Diseases of the Navy of the United States (Dr. Silvia M. Montano)
University of Washington (UW):
International Programme on AIDS Research and Training at UW (Dr. Carey Farquhar)
International Training Grant for Operations Research and Health Services AIDS and Tuberculosis (Dr. Joseph Zunt)
Research and Training Program in Medical Informatics "Amauta" (Dr. Ann Marie Kimball)
The UW CFAR Core and Peruvian CTU Training Mentoring Partnership (Dr. Ann Collier)
International Center for HIV Education and Training (Dr. Ann Downer)
Department of Global Health (Dr. King Holmes)
Focal Points Leaders Sponsored Clinical Research Locations by U.S. NIH
Dr. Beatriz Grinsztejn (Oswaldo Cruz Foundation, Rio de Janeiro, Brazil),
Dr. Mauro Schecter (Universidade Federal do Rio de Janeiro, Brazil),
Dr. Esper Kallas (Federal University of Sao Paulo, Brazil),
Dr. Breno Santos (Hospital Nossa Senora da Conciecao, Porto Alegre, Brazil)
Dr. Marcello Losso (COORDINATION Academic Clinical Research in Latin America-CICAL, Buenos Aires, Argentina),
Dr. Orlando Montoya (Ecuadorian Foundation Equity, Guayaquil, Ecuador),
Dr. Nestor Sosa (Medical Research Center, Panama City, Panama)
Dr. Yeycy Donastorg (Dermatological Institute, Santo Domingo, Dominican Republic),
Dr. Carmen Zorrilla (University of Puerto Rico, Puerto Rico), Juan Sierra (National Institute of Medical Sciences and Nutrition Salvador Subirán, Mexico)
Dr. Martin Casapia (Amazon rainforest, Iquitos, Peru),
Dr. Jorge Sanchez (IMPACTA, Lima, Peru)
Dr. Aldo Lucchetti (HUGE, Lima, Peru)
The activities and academic programs INCAS (courses, events, masters, courses, etc..) Will be established according to the training needs identified in an evaluation from the headquarters of Latin American research sponsored by the U.S. NIH. These activities would be training programs including:
- Epidemiology and Prevention
- Biology and Pathogenesis of HIV
- Clinical research, treatment and care
- Social and Behavioral Research
- Operations Research
INCA provides parallel development of training and research activities, whether in the context of ongoing projects or from the design and implementation of new studies. Projects may include topics such as:
I. Biology and Pathogenesis of HIV
I.1. Basic Retrovirology
I.2. Viral Diversity and Bioinformatics
I.5. HIV resistance to drugs
I.6. HIV Vaccines and Microbicides
I.7. Gene Therapy
Biology basics of HIV-1 and the host response to infection with HIV-1. Virus Genetics, evolution, structure and function, pathogenesis of HIV disease, innate and adaptive immune responses to HIV-1, HIV genetic susceptibility, and progress in animal models. Preclinical development of vaccines, microbicides and drugs.
II. Clinical research, treatment and care
II.1. Course of infection and disease
II.2. Diagnostic and monitoring tools
II.3. Diseases associated with HIV
II.4. Antiretroviral Therapies
II.5. Health systems and the provision of antiretroviral therapy
II.6. Topics related to specific populations
II.7. Complications of therapy
II.9. Other therapies
II.10. Provision of therapies and care
Research monitoring and diagnostic tools for HIV and the provision of health care. Evaluation results of ARV programs and ARV delivery models at national, regional and local levels, and their impact on health services and their integration with these. Approaches to care, support and treatment for specific populations (such as children, adolescents, pregnant women, etc..) Research on diagnosis, natural history and management of HIV infection, including antiviral therapy, diagnosis and treatment of opportunistic infections, co-infections and other concomitant health conditions other than AIDS. Different aspects of antiretroviral therapy, including new drugs, pharmacokinetics and drug interactions, adherence, adverse effects and HIV resistance to drugs.
III. Epidemiology, prevention and prevention research
III.1. Epidemiology of HIV / AIDS
III.2. Methodological issues and capacity building in epidemiological research and prevention
III.3. Surveillance of HIV / AIDS and STIs, monitoring and evaluation
III.4. Evaluation of biomedical interventions for HIV prevention
III.5. Evaluation of behavioral interventions for HIV prevention
III.5. Prevention programs
Understanding the epidemic and design, implementation and evaluation of programs and HIV prevention interventions. Discussion of approaches to reduce new HIV infections and mortality. Qualitative and quantitative methods to assess the risk and vulnerability to HIV, and to understand and follow the course of the epidemic, as well as the application of such methods in improving interventions, programs and policies for the prevention and control of HIV . Evaluation of interventions. New approaches to prevention. Best practices in HIV prevention in vulnerable populations. Analysis of approaches to programs and the implementation of HIV prevention initiatives, as well as coverage and impact assessments. This category covers the full continuum of prevention research from socio-behavioral research, and through intervention trials and evaluation studies. Strategies to increase the capacity and sustainability of HIV prevention, and approaches to translate research results into prevention practices and new prevention technologies.
IV. Social sciences, economic and behavioral
IV.1. Economic and social contexts
IV.2. Gender, age, ethnicity
IV.3. Sexuality, sexual behavior and sexual cultures
IV.4. Illicit drugs and substance abuse
IV.5. Living with HIV / AIDS
IV.6. Economy and Social
IV.7. Methods and theories in social sciences, economics and behavioral
IV.8. Evaluation of responses and national AIDS programs
This category covers four main areas and their different methodological approaches: 1) Factors promoting the epidemic, including poverty, sexuality, drug use, gender relations and globalization, and how these elements have an impact on risk and vulnerability. Relations between AIDS and broader issues such as war, violence and insecurity, intergenerational issues, labor and trade relations, and social movements, among others. 2) Impact of the epidemic, and understanding and impact mitigation. 3) Consideration of how the fight against the epidemic affects overall health, the operation and financing of health systems, as well as economic growth and human development. How are assigned resources (financial, technical, educational and human) in the fight against the epidemic. Relations between AIDS and global inequalities, social justice, health inequities (including women, migrants, indigenous peoples and prisoners). Analysis of the social, economic and political at all levels-individual, family, community, national and global levels. 4) Progress in HIV-related theory, including theories on sexuality, gender, equity, and social and economic change.
V. Policy and Political Science
V.1. Political, policy and activism
V.2. Policy implementation and impact
V.3. Analysis, monitoring and evaluation of policies
V.4. Human rights, ethics and legislation. Stigma and discrimination.
V.5. Roles and responsibilities of stakeholders
V.6. Security, international relations and humanitarian disasters
V.7. Answers and Financing
V.8. Impact of AIDS in other policy areas
Policy issues, politics and international relations. Globalization, global inequities, macroeconomics, social policies related to the epidemic or the implementation of initiatives, including the relationships between evidence, policy and funding. Progress and lessons learned into policies and activism related to AIDS. Role of activism in policy formulation. Human rights and ethics in the response to AIDS. Legislation, regulations and codes of practice. Policy evaluation and comparative studies.
Once implemented INCA activities will start the identification, selection and recruitment of American participants through associated focal points in each country program. Potential candidates must demonstrate excellence in their field of interest and a strong commitment to AIDS research.
All candidates will make their application from their home country and will be required to maintain a permanent position in an academic institution, research or government in their country.
The Latin American Program for Research and Training in AIDS - INCAS,SISDOC platform used to implement training activities.
Access to the platform located in the intranet resources is by invitation IMPACTA INCAS team.